Literature DB >> 5098918

Mitral valve disease, systemic embolism and anticoagulants.

H A Fleming, S M Bailey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5098918      PMCID: PMC2467310          DOI: 10.1136/pgmj.47.551.599

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  12 in total

1.  MITRAL STENOSIS AND SYSTEMIC EMBOLI.

Authors:  D LILLICRAP; A PIESOWICZ
Journal:  Br Med J       Date:  1964-11-07

2.  SYSTEMIC EMBOLISM IN MITRAL STENOSIS: RELATION TO THE SIZE OF THE LEFT ATRIAL APPENDIX.

Authors:  W SOMERVILLE; R J CHAMBERS
Journal:  Br Med J       Date:  1964-11-07

3.  PATIENTS WITH MITRAL STENOSIS AND SYSTEMIC EMBOLI; HEMODYNAMIC AND CLINICAL OBSERVATIONS.

Authors:  L CASELLA; W H ABELMANN; L B ELLIS
Journal:  Arch Intern Med       Date:  1964-12

4.  SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE.

Authors:  P SZEKELY
Journal:  Br Med J       Date:  1964-05-09

5.  SYSTEMIC HYPERTENSION AND MITRAL VALVE DISEASE.

Authors:  H I OBEYESEKERE; M DULAKE; H DEMERDASH; R HOLLISTER
Journal:  Br Med J       Date:  1965-08-21

6.  The myocardial factor in mitral valve disease.

Authors:  H A FLEMING; P WOOD
Journal:  Br Heart J       Date:  1959-01

7.  Prevention of systemic arterial embolism in chronic rheumatic heart disease by means of protracted anticoagulant therapy.

Authors:  J C WOOD; H L CONN
Journal:  Circulation       Date:  1954-10       Impact factor: 29.690

8.  An appreciation of mitral stenosis. I. Clinical features.

Authors:  P WOOD
Journal:  Br Med J       Date:  1954-05-08

9.  Transient visual obscurations in chronic rheumatic heart-disease.

Authors:  M Swash; C J Earl
Journal:  Lancet       Date:  1970-08-15       Impact factor: 79.321

10.  Systemic embolism in mitral valve disease.

Authors:  N Coulshed; E J Epstein; C S McKendrick; R W Galloway; E Walker
Journal:  Br Heart J       Date:  1970-01
View more
  24 in total

Review 1.  [Review of plasma anti-aggregants and their indications in primary care. Eight years later].

Authors:  M Blasco Valle; J F Lucía Cuesta
Journal:  Aten Primaria       Date:  2003-03-15       Impact factor: 1.137

Review 2.  Antithrombotic treatment in atrial fibrillation.

Authors:  L Kalra; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

Review 3.  Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.

Authors:  J R Stratton
Journal:  West J Med       Date:  1989-08

4.  Anticoagulants after mitral valvotomy.

Authors:  H A Fleming
Journal:  Br Med J       Date:  1973-04-14

5.  Anticoagulants in mitral valve disease.

Authors: 
Journal:  Br Med J       Date:  1972-03-11

6.  A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.

Authors:  J C Forfar
Journal:  Br Heart J       Date:  1979-08

7.  Increased levels of markers of oxidative stress and inflammation in patients with rheumatic mitral stenosis predispose to left atrial thrombus formation.

Authors:  Vinay Kumar Pulimamidi; Vengatesan Murugesan; Medha Rajappa; Santhosh Satheesh; Kottenyen Thazhath Harichandrakumar
Journal:  J Clin Diagn Res       Date:  2013-11-10

8.  Cerebral embolism and mitral stenosis: survival with and without anticoagulants.

Authors:  G F Adams; J D Merrett; W M Hutchinson; A M Pollock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

Review 9.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 10.  Risk of haemorrhage associated with long term anticoagulant therapy.

Authors:  M N Levine; G Raskob; J Hirsh
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.